Cogstate Limited

CHIA:CGS Stock Report

Market Cap: AU$170.9m

Cogstate Management

Management criteria checks 3/4

Cogstate's CEO is Brad O'Connor, appointed in Dec 2005, has a tenure of 18.92 years. total yearly compensation is $1.23M, comprised of 31.2% salary and 68.8% bonuses, including company stock and options. directly owns 3.15% of the company’s shares, worth A$5.38M. The average tenure of the management team and the board of directors is 3.8 years and 4 years respectively.

Key information

Brad O'Connor

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage31.2%
CEO tenure18.9yrs
CEO ownership3.1%
Management average tenure3.8yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Brad O'Connor's remuneration changed compared to Cogstate's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024US$1mUS$385k

US$5m

Mar 31 2024n/an/a

US$5m

Dec 31 2023n/an/a

US$6m

Sep 30 2023n/an/a

US$5m

Jun 30 2023US$1mUS$363k

US$4m

Mar 31 2023n/an/a

US$4m

Dec 31 2022n/an/a

US$3m

Sep 30 2022n/an/a

US$6m

Jun 30 2022US$2mUS$346k

US$8m

Mar 31 2022n/an/a

US$9m

Dec 31 2021n/an/a

US$10m

Sep 30 2021n/an/a

US$7m

Jun 30 2021US$1mUS$344k

US$5m

Mar 31 2021n/an/a

US$3m

Dec 31 2020n/an/a

US$335k

Sep 30 2020n/an/a

-US$811k

Jun 30 2020US$931kUS$371k

-US$2m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019n/an/a

-US$3m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019US$655kUS$368k

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018n/an/a

-US$1m

Sep 30 2018n/an/a

-US$907k

Jun 30 2018US$783kUS$338k

-US$566k

Compensation vs Market: Brad's total compensation ($USD1.23M) is above average for companies of similar size in the Australian market ($USD296.04K).

Compensation vs Earnings: Brad's compensation has been consistent with company performance over the past year.

CEO

Brad O'Connor

18.9yrs

Tenure

US$1,232,152

Compensation

Mr. Bradley John O'Connor, also known as Brad, B.Bus, CA, has been the Chief Executive Officer and Managing Director of Cogstate Limited since December 1, 2005 and served as its Chief Financial Officer sin...

Leadership Team

NamePositionTenureCompensationOwnership
Bradley O'Connor
CEO, MD & Executive Director18.9yrsUS$1.23m3.15%
A$ 5.4m
Darren Watson
Chief Financial Officer3.8yrsUS$497.19kno data
Rachel Colite
Executive VP of Clinical Trials1.4yrsUS$495.76k0.11%
A$ 184.8k
Paul Maruff
Founder & Chief Innovation Officerno datano datano data
Kristi Geddes
General Counsel1.6yrsno datano data
Kenneth Billard
Chief Commercial Officer5yrsUS$436.14kno data
Kaycee Sink
Chief Medical Officerless than a yearno datano data
David Franks
Joint Company Secretary3.8yrsno datano data

3.8yrs

Average Tenure

Experienced Management: CGS's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Bradley O'Connor
CEO, MD & Executive Director18.9yrsUS$1.23m3.15%
A$ 5.4m
Kristi Geddes
General Counselno datano datano data
Richard van den Broek
Independent Non-Executive Director14.3yrsUS$57.96k2.58%
A$ 4.4m
Martyn Myer
Non-Executive Chairman24.9yrsUS$95.67k13.74%
A$ 23.5m
Ingrid Player
Independent Non-Executive Director5.3yrsUS$71.76k0.078%
A$ 132.8k
Kim Wenn
Independent Non-Executive Director4yrsUS$64.92k0.0073%
A$ 12.5k
Richard Mohs
Independent Non-Executive Director7.8yrsUS$64.78k0.039%
A$ 66.3k
Sharon Cohen
Member of Scientific Advisory Board2.4yrsno datano data
Eric Siemers
Distinguished Medical Adviser & Chairman of Scientific Advisory Board2.4yrsno datano data
Bruce Albala
Member of Scientific Advisory Board2.4yrsno datano data
Adam Brickman
Member of Scientific Advisory Board2.4yrsno datano data
Kate Papp
Member of Scientific Advisory Board2.4yrsno datano data

4.0yrs

Average Tenure

62yo

Average Age

Experienced Board: CGS's board of directors are considered experienced (4 years average tenure).